Active

Conrad Pharma

Switched

BE0536875697

Rechtspersoon Private limited company 1 establishment

Diependale 8, 9700 Oudenaarde Detailhandel in farmaceutische producten

Active for

13 year, 1 month

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 504,793

▲ 17% vs 2024

Profit

Growing

€ 199,229

▲ 6% vs 2024

Debts

Normal

€ 3.9 million

▼ 13% vs 2024

Conrad Pharma from Oudenaarde, company number BE0536875697, closed financial year 2025 with a result of € 199,229 after tax. For that financial year Conrad Pharma recorded a gross margin of € 504,793 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 188,587 to € 199,229. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What happened at Conrad Pharma?

What happened at Conrad Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 199,229 (▲ 6% vs 2024). filed late Source: NBB ↗
  • New establishment in Maarkedal. KBO
  • Start of the company according to the CBE. KBO

In short

From € 189,356 profit in 2021 to € 199,229 profit in 2025.

Paid € 330,290 in corporate taxes since 2021.

Best year ever: 2022, with € 295,505 profit.

On average € 201,900 of value added per employee in 2025.

A new publication or filing at Conrad Pharma? We notify you, reason included.

Follow Conrad Pharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Philippe Verzele
Vanessa Pluym
Conrad Pharma

Behind Conrad Pharma are Philippe Verzele and Vanessa Pluym. It owns 100% of Verzele Pharma, 100% of Decaphar, 100% of Verzele Pharma Zwalm and 100% of Geva Pharma itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Philippe Verzele

Director

Also active at: GEVA PHARMA, VERZELE PHARMA ZWALM, DECAPHAR +1 more

Vanessa Pluym

Director

Also active at: GEVA PHARMA, VERZELE PHARMA ZWALM, DECAPHAR +1 more

Establishments

Establishment units

Physical locations of this company

Registered office

Diependale 8

9700 Oudenaarde

2.223.673.827

Nukerkestraat 2

9681 Maarkedal

Active since 1 August 2013

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0536.875.697
VAT number
BE 0536.875.697
Registered office
Diependale 8, 9700 Oudenaarde
Names & denominations
Conrad Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
23 July 2013
Peppol
Active · Active since 19 Nov 2025
Activities · NACE

Detailhandel in farmaceutische producten

Overige zakelijke dienstverlening, neg

Frequently asked questions

What is the enterprise number of Conrad Pharma?
The enterprise number of Conrad Pharma is BE0536875697.
What is the address of Conrad Pharma?
The registered office of Conrad Pharma is located at Diependale 8, 9700 Oudenaarde.
When was Conrad Pharma founded?
Conrad Pharma was founded on 23 July 2013.
What is the main activity of Conrad Pharma?
The main activity of Conrad Pharma is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does Conrad Pharma have a website?
No website is currently known for Conrad Pharma.
How much profit did Conrad Pharma make in 2025?
Conrad Pharma posted a profit after taxes of € 199,229 in financial year 2025.
What is the revenue of Conrad Pharma?
As a small company, Conrad Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 504,793.
How many employees does Conrad Pharma have?
According to the 2025 annual accounts, Conrad Pharma has 2.5 full-time equivalents (FTE).
Where can I find the annual accounts of Conrad Pharma?
Conrad Pharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Conrad Pharma?
According to the 2025 annual accounts, the directors of Conrad Pharma are: Philippe Verzele, Vanessa Pluym.
Who owns Conrad Pharma?
Behind Conrad Pharma are Philippe Verzele and Vanessa Pluym. It owns 100% of Verzele Pharma, 100% of Decaphar, 100% of Verzele Pharma Zwalm and 100% of Geva Pharma itself.